Merck KGaA (OTCMKTS:MKKGY) Shares Shorted: Short Interest Up 1,031.1% in September

Posted by Tyrone Williams on Oct 9th, 2026

Merck KGaA (OTCMKTS:MKKGY – Get Free Report) saw a significant increase in short interest in September. As of September 30th, there was short interest totaling 39,149 shares, an increase of 1,031.1% from the September 15th total of 3,461 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average trading volume of 131,328 shares, the short-interest ratio is presently 0.3 days.

Wall Street Analysts Forecast Growth

MKKGY has been the topic of a number of recent analyst reports. UBS Group downgraded Merck KGaA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 20th. HSBC raised Merck KGaA to a “hold” rating in a research report on Monday, July 6th. Finally, Zacks Research downgraded Merck KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 20th. Six equities research analysts have rated the stock with a Hold rating. According to MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Check Out Our Latest Research Report on Merck KGaA

Merck KGaA Stock Performance

MKKGY stock traded up $0.28 during midday trading on Friday, reaching $31.06. The stock had a trading volume of 136,237 shares, compared to its average volume of 157,301. The firm has a fifty day simple moving average of $31.60 and a two-hundred day simple moving average of $30.09. Merck KGaA has a 52-week low of $23.73 and a 52-week high of $34.19. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.09 and a current ratio of 1.69. The stock has a market cap of $20.07 billion, a PE ratio of 16.01, a P/E/G ratio of 2.91 and a beta of 0.95.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest pharmaceutical and chemical businesses. The company operates independently from Merck & Co, Inc, the U.S.-based company that uses the Merck name in the United States and Canada.

Merck KGaA operates through three primary business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, analytical technologies and bioprocessing solutions used by pharmaceutical and biotechnology companies, academic institutions and industrial laboratories.